Heritable amegacariocytic thrombocytopenia: description of aclinical case

Dudnyk, V. M.; Furman, V. G.; Kutsak, O. V.; Izyumets, O. I.

dc.contributor.author	Dudnyk, V. M.	en
dc.contributor.author	Furman, V. G.	en
dc.contributor.author	Kutsak, O. V.	en
dc.contributor.author	Izyumets, O. I.	en
dc.date.accessioned	2022-05-17T07:43:32Z
dc.date.available	2022-05-17T07:43:32Z
dc.date.issued	2022
dc.identifier.citation	Heritable amegacariocytic thrombocytopenia: description of aclinical case / V. M. Dudnyk, V. G. Furman, O. V. Kutsak, O. I. Izyumets // Вісник Вінницького національного медичного університету. - 2022. - Т. 26, № 1. – C. 27-30.	en
dc.identifier.uri	https://dspace.vnmu.edu.ua/123456789/5644
dc.description.abstract	Features of the clinical course and differential diagnosis of hereditary thrombocytopenia, characterized by the development of pancytopenia in childhood, are described. It was found that the main manifestation of this pathology is hemorrhagic syndrome, accompanied by the presence of polymorphic, polychrome, asymmetric hemorrhagic rashes, frequent bleeding from the mucous membranes. The Mpl gene (1p34) was sequestered to confirm the diagnosis and establish the genomic mutation. Complex diagnosis of this disease requires a comprehensive and interdisciplinary approach involving a coordinated team of hematologists, geneticists, immunologists, neurosurgeons and ophthalmologists.	en
dc.language.iso	en	en
dc.subject	children	en
dc.subject	thrombocytopenia	en
dc.subject	hemorrhagic syndrome	en
dc.subject	gen Mpl (1p34)	en
dc.title	Heritable amegacariocytic thrombocytopenia: description of aclinical case	en
dc.type	Article	en